The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of regorafenib alone or in combinations in the second-line setting for advanced hepatocellular carcinoma: A multicenter real-world study.
 
Wei Zhang
No Relationships to Disclose
 
Yanrong Zhao
No Relationships to Disclose
 
Guixiang Ma
No Relationships to Disclose
 
Yu Zhang
No Relationships to Disclose
 
Yuan Guo
No Relationships to Disclose
 
Zhong Chen
No Relationships to Disclose